Gender Disaggregation in COVID-19 and Increased Male Susceptibility.


Journal

Journal of Nepal Health Research Council
ISSN: 1999-6217
Titre abrégé: J Nepal Health Res Counc
Pays: Nepal
ID NLM: 101292936

Informations de publication

Date de publication:
13 Nov 2020
Historique:
received: 25 09 2020
accepted: 13 11 2020
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Novel coronavirus disease 2019 (COVID-19) is a growing public health crisis. Despite initial focus on the elderly population with comorbidities, it seems that large studies from the worst affected countries follow a sex-disaggregation pattern. Analysis of available data showed marked variations in reported cases between males and females among different countries with higher mortality in males.  At this early stage of the pandemic, medical datasets at the individual level are not available; therefore, it is challenging to conclude how different factors have impacted COVID-19 susceptibility. Thus, in the absence of patients' level data, we attempted to provide a theoretical description of how other determinants have affected COVID-19 susceptibility in males compared to females.  In this article, we have identified and discussed possible biological and behavioral factors that could be responsible for the increased male susceptibility. Biological factors include - an absence of X-chromosomes (a powerhouse for immune-related genes), a high level of testosterone that inhibits antibody production, and the presence of Angiotensin-converting enzyme 2 (ACE2) receptors that facilitate viral replication. Similarly, behavioral factors constitute - higher smoking and alcohol consumptions, low level of handwashing practices, and high-risk behavior like non-adherence to health services and reluctance to follow public health measures in males. Keywords: COVID-19; gender; males; sex disaggregation; susceptibility.

Identifiants

pubmed: 33210622
doi: 10.33314/jnhrc.v18i3.3108
doi:

Substances chimiques

Testosterone 3XMK78S47O
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-350

Auteurs

Yogesh Acharya (Y)

Western Vascular Institute, Galway University Hospital, National University of Ireland, Galway, Ireland.

Suman Pant (S)

Nepal Health Research Council, Kathmandu, Nepal.

Pradip Gyanwali (P)

Nepal Health Research Council, Kathmandu, Nepal.

Ganesh Dangal (G)

Nepal Health Research Council, Kathmandu, Nepal.

Priyanka Karki (P)

Nobel Medical College Teaching Hospital, Biratnagar, Nepal.

Navindra Raj Bista (NR)

Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Meera Tandan (M)

Cecil G Sheps Center for Health Service Research, University of North Carolina, Chapel Hill, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH